Skip to main content

Day Zero Diagnostics epiXact WGS Sequencing Service

Day Zero Diagnostics (DZD) has commercially launched its epiXact whole genome sequencing and analysis service for hospital-acquired infection outbreak investigations. According to DZD, the service allows hospital infection control teams to determine the relationships between infections during a suspected outbreak. The firm said that the service can provide results in two to three days and can help hospital confidently and quickly decide how to perform interventions for patient safety. 

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.